Shoshanna Fischhoff

NeuroNetwork faculty member earns the Early Distinguished Career Award for his exemplary leadership in research, education and clinical care.

The Department of Neurosurgery announced that Eva Feldman, M.D., Ph.D., would receive a joint appointment as a Professor of Neurosurgery.

A knowledge exchange from across the pond has brought two visiting scholars from Europe to the NeuroNetwork for Emerging Therapies lab.

His research will investigate neuron dysregulation in Alzheimer’s disease and other disorders with the goal of developing new therapeutic approaches.

Mohamed Noureldein, Ph.D., and Samuel Teener were awarded the Simona Frontini Young Investigators Award for Most Innovative Research Presentation.

A 27-year-old University of Michigan alumna turned an ALS diagnosis into an opportunity to create a community of support for those like her—young women faced with the deadly disease.

Dr. Kevin Chen led a team that reviewed “Stem cell therapeutics and gene therapy for neurologic disorders.”

Brian Callaghan, M.D., M.S., was part of a team that published findings that there are “Possible sex and racial disparities in myasthenia gravis care.”

Michigan Medicine's Center for Cell Plasticity and Organ Design featured NeuroNetwork neuropathy research in their "Faculty Publication Spotlight."

Eva Feldman, M.D., Ph.D., sat down with Mark Mattson, Ph.D., Adjunct Professor of Neurology at Johns Hopkins, for his podcase Brain Ponderings to discuss the importance of research on the exposome in neurologic disease.

Researchers reviewed the latest research on obesity-related neuropathy and possible treatment options.

Neurology published findings from an international group of scientists, including Brian Callaghan, M.D., M.S., that linked blood fatty acid levels to neuropathy.

Mohamed Noureldein, Ph.D., was named an inaugural Brehm-Concordia Scholar.

Eva Feldman, M.D., Ph.D., was part of a committee put together by the National Academies of Sciences, Engineering and Medicine (NASEM) to identify and recommend key actions for the public, private, and nonprofit sectors to undertake to make ALS a livable disease within a decade.

Stacey Jacoby, Ph.D., received the Research Study Coordinator/Manager Recognition Award.